期刊文献+

蛋白C、蛋白S和抗凝血酶Ⅲ与Rex手术预后的关系研究 被引量:6

Relationship between protein C, protein S and antithrombin Ⅲ and prognosis in children undergoing Rex shunt
原文传递
导出
摘要 目的探讨蛋白C(PC)、蛋白S(PS)和抗凝血酶Ⅲ(ATⅢ)与小儿肝外门静脉高压Rex手术预后的相关关系。方法2013年12月至2016年4月53例肝外门静脉高压患儿于首都儿科研究所接受Rex手术治疗和术后定期随访复查,男32例,女21例。收集手术前后的血液样本,17例复发组血液样本来自于13例Rex术后复发患儿出血收集的血液,40例未复发组血液样本来自于40例Rex术后无消化道出血者。正常儿童血液样本18例作为对照组。采用PC、PS和ATⅢ试剂盒检测血液中PC、PS和ATⅢ浓度和活性水平。术后随访患儿预后,包括B型超声监测分流血管直径和流速、腹部增强CT、血常规、生化和凝血功能及有无出血情况。根据患儿术后有无出血,将患儿分为复发组和未复发组,比较Rex术后PC、PS和ATⅢ与正常对照组的差别,比较Rex术后复发组与未复发组的差别。根据术后超声及腹部增强CT监测分流血管直径,将Rex术后未复发患儿分为分流血管直径大于(等于)5 mm组和直径小于5 mm组。比较直径大于5 mm组、直径小于5 mm组、复发组和对照组的差别。结果通过比较Rex术后患儿与正常对照组的差别发现,复发组的ATⅢ活性和PS较正常对照组明显降低,分别为(55.6±4.8) U/ml和(61.7±5.1) U/ml(P=0.003),(1.9±0.2) μg/ml比(2.4±0.2) μg/ml(P=0.000),两组之间PC和ATⅢ浓度差异无统计学意义(P=0.109和0.085)。复发组的ATⅢ活性明显低于未复发组,分别为(55.6±4.8) U/ml和(59.8±6.4) U/ml(P=0.015),两组之间的PC、PS和ATⅢ浓度差异无统计学意义(P=0.253、1.000、0.677)。复发组的ATⅢ活性明显低于直径大于5 mm组,分别为(55.6±4.8) U/ml和(60.4±6.2) U/ml(P=0.010),而与直径小于5 mm组相比,分别为(55.6±4.8) U/ml和(58.7±6.8) U/ml,差异无统计学意义(P=0.140)。Rex术后复发与食管静脉曲张程度明显相关(P=0.013)。食管静脉曲张者的ATⅢ活性明显低于无食管静脉曲张者(P=0.015)。结论血清ATⅢ活性降低与小儿肝外门静脉高压Rex术后复发及食管静脉曲张有明显相关关系,是监测Rex术后预后不良的重要指标,可能与入肝血流减少有关。 ObjectiveTo explore the relationship between protein C, protein S and antithrombin Ⅲ and prognosis in children undergoing Rex shunting.MethodsFrom December 2013 to April 2016, 53 children (32 boys and 21 girls) with portal cavernous underwent Rex shunting. Both pre- and post-operative blood samples were collected. The blood samples of 18 normal children were used as control group. The concentration of protein C (PC), protein S (PS) and antithrombin Ⅲ (ATⅢ) and activity of antithrombin Ⅲ were detected by enzyme-linked immunosorbent assay (ELISA) Kit. Based on post-shunting prognosis, they were grouped into re-bleeding and non-bleeding groups. The values of PC, PS and ATⅢ between re-bleeding and non-bleeding groups and control group were compared. Based on the diameter of bypass vein as measured by postoperative sonography and computed tomography (CT), they were grouped into no less than 5 mm and 〈5 mm groups. PC, PS and AT Ⅲ were compared between no less than 5 mm and less than 5 mm groups and re-bleeding group.ResultsThe activity of ATⅢ and concentration of PS were significantly lower in re-bleeding group than those in control group (55.6±4.8 vs 61.7±5.1 U/ml, P=0.003; 1.9±0.2 vs 2.4±0.2 μg/ml, P=0.000). No difference existed in the concentration of PC and ATⅢ between re-bleeding and control groups (P=0.109 & 0.085). The activity of ATⅢ was significantly lower in re-bleeding group than that in non-bleeding group (55.6±4.8 vs 59.8±6.4 U/ml, P=0.015). No difference existed in concentrations of PC, PS and ATⅢ between re-bleeding and non-bleeding groups (P=0.253, P=1.000 and P=0.677). The activity of ATⅢ was significantly lower in re-bleeding group than that in no less than 5 mm group (55.6±4.8 vs 60.4±6.2 U/ml, P=0.010). No difference existed in the activity of ATⅢ between re-bleeding and 〈5 mm groups (55.6±4.8 vs 58.7±6.8 U/ml, P=0.140).ConclusionsReduced activity of ATⅢ is significant in re-bleeding children after Rex shunting. As an important prognostic indicator of Rex shunting, it may be a result of decreased hepatopetal blood flow.
作者 张金山 李龙 侯文英 Zhang Jinshan;Li Long;Hou Wenying(Department of General Surgery,Capital Institute of Pediatrics,Beijing 100020,China)
出处 《中华小儿外科杂志》 CSCD 北大核心 2018年第10期734-738,共5页 Chinese Journal of Pediatric Surgery
基金 国家自然科学基金(81770595) 首都卫生发展科研专项(首发2016-4-2104) 北京市自然科学基金(7164242) 北京市属医院科研培育项目(PX2016003) 北京市医院管理局“青苗计划”(QML20161304)
关键词 高血压 门静脉 Rex手术 预后 Hypertension portal Rex shunt Prognosis
  • 相关文献

参考文献2

二级参考文献27

  • 1de Ville de Goyet J, Clapuyt P, Otte JB. Extrahilar mesenterico-left portal shunt to relieve extrahepatic portal hypertension after partial liver transplant [ J ]. Transplantation, 1992,53(1):231-232.
  • 2Poddar U, Borkar V. Management of extra hepatic portal venous obstruction (EHPVO).. current strategies[J]. Trop Gastroenterol, 2011, 32(2): 94-102.
  • 3Shinkai M, Ohhama Y, Honda S, et al. Recanalized umbilical vein as a conduit for mesenterico/porto-Rex bypass for patients with extrahepatie portal vein obstruction[J]. Pediatr Surg Int, 2011, 27(3) :315-319.
  • 4Cho YP, Ha TY, Ko GY, et al. Use of meso-Rex shunt with transposition of the coronary vein for the management of extrahepatic portal vein obstruction[J]. Ann Surg Treat Res, 2014, 86(2) : 105-108.
  • 5Ate~ O, Hakgiider G, Olguner M, et al. Extrahepatic portal hypertension treated by anastomosing inferior mesenteric vein to left portal vein at Rex reeessus[J]. J Pediatr Surg, 2003, 38(10) : E10-11.
  • 6Chen VT, Wei J, Lin VC. A new procedure for management of extrahepatic portal obstruction: proximal splenic-left intrahepatic portal shunt[J].Arch Surg, 1992, 127(11):1358-1360.
  • 7Fuchs J, Warmann S, Kardorff R, et al. Mesenterico-leftportal vein bypass in children with congenital extrahepatic portal vein thrombosis: a unique curative approach [J]. J Pediatr Gastroenterol Nutr, 2003, 36(2): 213-216.
  • 8Zhang JS, Li L, Liu SL, et ak Gastmportal shunt for portal hypertension in children[J]. J Pediatr Surg,2012,47(1):253-257.
  • 9Ate~ O, Hakgiider G, Olguner M, et al. Mesenterico left portal bypass for variceal bleeding owing to extrahepatic portal hypertension caused by portal vein thrombosis[J]. J Pediatr Surg, 2006, 41(7):1259-1263.
  • 10Dasgupta R, Roberts E, Superina RA, et al. Effectiveness of Rex bypass in the treatment of portal hypertension[J]. J Pediatr Surg, 2006, 41(1):108-112.

共引文献18

同被引文献34

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部